Treatment of Dyslipidemia

Introduction

Extensive research and clinical outcomes analysis have demonstrated the increased risk of coronary heart disease in patients with dyslipidemia and hyperlipidemia. Elevated low density lipoprotein cholesterol (LDL-c) has specifically been shown to increase the risk of coronary heart disease (CHD) and many recent trials have shown a significant improvement in mortality with LDL-c lowering therapy.

Abstract

A large body of research and clinical outcomes analysis has demonstrated the increased risk of coronary heart disease in patients with dyslipidemia and hyperlipidemia and the effectiveness of targeted intervention. In this article we review the management options for this disease process. The recommended treatment approach starts with lifestyle modifications and suggests primary and secondary medication options for patients who require pharmacologic intervention.

Keywords

dyslipidemia, coronary heart disease, treatment, lipoproteins, coronary artery disease, statins